European Journal of Heart Failure

Editiorial board
pp. iii-iii(1)

A method to reduce loss to follow-up in clinical trials: informed, withdrawal of consent
pp. 1-2(2)
Authors: Cleland J.G.F.; Torp-Pedersen C.; Coletta A.P.; Lammiman M.J.

Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure
pp. 3-9(7)
Authors: Diedrichs H.; Chi M.; Boelck B.; Mehlhorm U.; Schwinger R.H.G.

Does angiotensin-converting enzyme gene polymorphism affect blood pressure? Findings after 6 years of follow-up in healthy subjects
pp. 11-16(6)
Authors: Di Pasquale P.; Cannizzaro S.; Paterna S.

Beta-adrenergic receptor blockade and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure
pp. 17-21(5)
Authors: de Groote P.; Helbecque N.; Lamblin N.; Hermant X.; Amouyel P.; Bauters C.; Dallongeville J.

Association of the angiotensin-converting enzyme gene polymorphism with chronic heart failure in Chinese Han patients
pp. 23-27(5)
Authors: Huang W.; Xie C.; Zhou H.; Yang T.; Sun M.

Basal and exercise-induced neuroendocrine activation in patients with heart failure and in normal subjects
pp. 29-39(11)
Authors: Kjaer A.; Appel J.; Hildebrandt P.; Petersen C.L.

Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure
pp. 41-45(5)
Authors: Yamazaki T.; Lee J.-D.; Shimizu H.; Uzui H.; Ueda T.

Determinants of platelet responsiveness to nitric oxide in patients with chronic heart failure
pp. 47-54(8)
Authors: Anderson R.A.; Ellis G.R.; Chirkov Y.Y.; Holmes A.S.; Payne N.; Blackman D.J.; Jackson S.K.; Lewis M.J.; Horowitz J.D.; Frenneaux M.P.

Diagnostic value of a rapid test for B-type natriuretic peptide in patients presenting with acute dyspnoe: effect of age and gender
pp. 55-62(8)
Authors: Wold Knudsen C.; Sigurd Riis J.; Finsen A.V.; Eikvar L.; Muller C.; Westheim A.; Omland T.

N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea
pp. 63-70(8)
Authors: Nielsen L.S.; Svanegaard J.; Anders Klitgaard N.; Egeblad H.

Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction
pp. 71-77(7)
Authors: Kjoller E.; Kober L.; Iversen K.; Torp-Pedersen C.; Trace Study Group o.b.o.t.

Systematic review of open access echocardiography for primary care
pp. 79-83(5)
Author: Khunti K.

Effect of tissue harmonic imaging and contrast upon between observer and test-retest reproducibility of left ventricular ejection fraction measurement in patients with heart failure
pp. 85-93(9)
Authors: Whalley G.A.; Gamble G.D.; Walsh H.J.; Wright S.P.; Agewall S.; Sharpe N.; Doughty R.N.

Does aerobic training lead to a more active lifestyle and improved quality of life in patients with chronic heart failure?
pp. 95-100(6)
Authors: van den Berg-Emons R.; Balk A.; Bussmann H.; Stam H.

Muscle strength as a predictor of long-term survival in severe congestive heart failure
pp. 101-107(7)
Authors: Hulsmann M.; Quittan M.; Berger R.; Crevenna R.; Springer C.; Nuhr M.; Mortl D.; Moser P.; Pacher R.

Clinical trials update from the American Heart Association meeting: -3 fatty acids and arrhythmia risk in patients with an implantable defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, ORBIT and PAD and DEFINITE
pp. 109-115(7)
Authors: Cleland J.G.F.; Freemantle N.; Kaye G.; Nasir M.; Velavan P.; Lalukota K.; Mudawi T.; Shelton R.; Clark A.L.; Coletta A.P.

Aspirin, ACE inhibitors and arterial stiffness
pp. 117-118(2)
Authors: Weber T.; Eber B.; Auer J.

Instructions to Authors
pp. 121-123(3)